Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Phage Therapy for the Prevention and Treatment of Pressure Ulcers.
Phase 1
- Conditions
- Pressure Ulcer
- First Posted Date
- 2021-03-25
- Last Posted Date
- 2021-12-21
- Lead Sponsor
- Precisio Biotix Therapeutics, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT04815798
Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients
Phase 1
- Conditions
- Wound Infection
- Interventions
- Drug: XeroformBiological: Bacteriophage cocktail spray
- First Posted Date
- 2020-03-26
- Last Posted Date
- 2021-12-22
- Lead Sponsor
- Precisio Biotix Therapeutics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04323475
News
No news found